Autologous Conditioned Serum

Christopher H Evans, Xavier Chevalier, Peter Wehling

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Autologous conditioned serum was developed in the mid 1990s as an expeditious, practical, and relatively inexpensive means of generating the interleukin-1 receptor antagonist, a naturally occurring inhibitor of the cytokine interleukin-1. The latter is thought to be an important mediator of inflammation, pain, and tissue destruction in musculoskeletal conditions. ACS has been widely and successfully used in the local treatment of human and equine osteoarthritis and radicular compression; it has also shown promise in treating tendinopathies, muscle injuries, and tunnel widening after reconstruction of the anterior cruciate ligament. Experience suggests that autologous conditioned serum is safe and effective.

Original languageEnglish (US)
Pages (from-to)893-908
Number of pages16
JournalPhysical Medicine and Rehabilitation Clinics of North America
Volume27
Issue number4
DOIs
StatePublished - Nov 1 2016

Fingerprint

Nociceptive Pain
Inflammation Mediators
Tendinopathy
Anterior Cruciate Ligament Reconstruction
Interleukin-1 Receptors
Serum
Interleukin-1
Osteoarthritis
Horses
Cytokines
Muscles
Wounds and Injuries
Therapeutics

Keywords

  • Anterior cruciate ligament
  • Interleukin-1 receptor antagonist
  • Intra-articular therapy
  • Muscle injury
  • Osteoarthritis
  • Pain
  • Radicular compression
  • Tendinopathy

ASJC Scopus subject areas

  • Physical Therapy, Sports Therapy and Rehabilitation
  • Rehabilitation

Cite this

Autologous Conditioned Serum. / Evans, Christopher H; Chevalier, Xavier; Wehling, Peter.

In: Physical Medicine and Rehabilitation Clinics of North America, Vol. 27, No. 4, 01.11.2016, p. 893-908.

Research output: Contribution to journalReview article

Evans, Christopher H ; Chevalier, Xavier ; Wehling, Peter. / Autologous Conditioned Serum. In: Physical Medicine and Rehabilitation Clinics of North America. 2016 ; Vol. 27, No. 4. pp. 893-908.
@article{475b8d4bc24c40d98b84ed4364aac163,
title = "Autologous Conditioned Serum",
abstract = "Autologous conditioned serum was developed in the mid 1990s as an expeditious, practical, and relatively inexpensive means of generating the interleukin-1 receptor antagonist, a naturally occurring inhibitor of the cytokine interleukin-1. The latter is thought to be an important mediator of inflammation, pain, and tissue destruction in musculoskeletal conditions. ACS has been widely and successfully used in the local treatment of human and equine osteoarthritis and radicular compression; it has also shown promise in treating tendinopathies, muscle injuries, and tunnel widening after reconstruction of the anterior cruciate ligament. Experience suggests that autologous conditioned serum is safe and effective.",
keywords = "Anterior cruciate ligament, Interleukin-1 receptor antagonist, Intra-articular therapy, Muscle injury, Osteoarthritis, Pain, Radicular compression, Tendinopathy",
author = "Evans, {Christopher H} and Xavier Chevalier and Peter Wehling",
year = "2016",
month = "11",
day = "1",
doi = "10.1016/j.pmr.2016.06.003",
language = "English (US)",
volume = "27",
pages = "893--908",
journal = "Physical Medicine and Rehabilitation Clinics of North America",
issn = "1047-9651",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Autologous Conditioned Serum

AU - Evans, Christopher H

AU - Chevalier, Xavier

AU - Wehling, Peter

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Autologous conditioned serum was developed in the mid 1990s as an expeditious, practical, and relatively inexpensive means of generating the interleukin-1 receptor antagonist, a naturally occurring inhibitor of the cytokine interleukin-1. The latter is thought to be an important mediator of inflammation, pain, and tissue destruction in musculoskeletal conditions. ACS has been widely and successfully used in the local treatment of human and equine osteoarthritis and radicular compression; it has also shown promise in treating tendinopathies, muscle injuries, and tunnel widening after reconstruction of the anterior cruciate ligament. Experience suggests that autologous conditioned serum is safe and effective.

AB - Autologous conditioned serum was developed in the mid 1990s as an expeditious, practical, and relatively inexpensive means of generating the interleukin-1 receptor antagonist, a naturally occurring inhibitor of the cytokine interleukin-1. The latter is thought to be an important mediator of inflammation, pain, and tissue destruction in musculoskeletal conditions. ACS has been widely and successfully used in the local treatment of human and equine osteoarthritis and radicular compression; it has also shown promise in treating tendinopathies, muscle injuries, and tunnel widening after reconstruction of the anterior cruciate ligament. Experience suggests that autologous conditioned serum is safe and effective.

KW - Anterior cruciate ligament

KW - Interleukin-1 receptor antagonist

KW - Intra-articular therapy

KW - Muscle injury

KW - Osteoarthritis

KW - Pain

KW - Radicular compression

KW - Tendinopathy

UR - http://www.scopus.com/inward/record.url?scp=84992653734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992653734&partnerID=8YFLogxK

U2 - 10.1016/j.pmr.2016.06.003

DO - 10.1016/j.pmr.2016.06.003

M3 - Review article

VL - 27

SP - 893

EP - 908

JO - Physical Medicine and Rehabilitation Clinics of North America

JF - Physical Medicine and Rehabilitation Clinics of North America

SN - 1047-9651

IS - 4

ER -